Results for cryosurgical ablation translation from English to Slovenian

ablation
ablacija

eyestalk ablation
odstranitev tipalke z očesom

ablation therapy;
zdravljenje s kirurško odstranitvijo;

dental cryosurgical units
zobne zamrzovalne operativne enote

cryosurgical and cryotherapy devices
naprave za kriokirurgijo in krioterapijo

dental cryosurgical, gauges, elevators and excavators
zobne zamrzovalne operativne enote, zobni merilniki globine, zobni elevatorji in zobni ekskavatorji

androgen ablation is considered to be a palliative treatment.
ablacija moškega spolnega hormona se šteje za paliativno zdravljenje.

in men with prostate cancer receiving hormone ablation, prolia significantly reduces the risk of vertebral fractures.
pri moških z rakom na prostati, ki prejemajo zdravljenje z ablacijo hormonov, zdravilo prolia znatno zmanjša tveganje zlomov vretenc.

for radioiodine imaging or ablation, radioiodine administration should be given 24 hours following the final thyrogen injection.
za scintigrafijo z radioaktivnim jodom ali ablacijo damo radioaktivni jod bolniku 24 ur po zadnjem injiciranju zdravila thyrogen.

when you undergo radioiodine imaging or ablation, your doctor will give you radioiodine 24 hours after your final thyrogen injection.
med scintigrafijo ali ablacijo z radioaktivnim jodom vam bo zdravnik dal radioaktivni jod 24 ur po zadnji injekciji zdravila thyrogen.

analyses of t3 patients and n1 patients showed that these subgroups had equally good ablation success rates as did lower-risk patients.
analize bolnikov t3 in bolnikov n1 so pokazale, da imata ti dve podskupini enako dobro uspešnost ablacije kot bolniki z manjšim tveganjem.

for the ablation of thyroid tissue, radioiodine imaging eight months after treatment showed that both treatments were 100% successful.
pri odstranjevanju ščitničnega tkiva je slikanje z radioaktivnim jodom osem mesecev po zdravljenju pokazalo, da sta bila oba načina zdravljenja 100% uspešna.

thyrogen has also been studied in the ablation of thyroid tissue in one study involving 63 patients with thyroid cancer, who received 131i either after thyrogen or after thst.
zdravilo thyrogen so preučevali tudi pri odstranjevanju ščitničnega tkiva v eni raziskavi s 63 bolniki z rakom ščitnice, ki so prejeli 131i bodisi po zdravilu thyrogen bodisi po prekinitvi thst.

the overall safety profile of prolia was similar in patients with osteoporosis and in breast or prostate cancer patients receiving hormone ablation in five phase iii placebo-controlled clinical trials.
v celoti so bile varnostne značilnosti zdravila prolia podobne pri bolnikih z osteoporozo ter bolnicah z rakom dojke ali bolnikih z rakom prostate, deležnih ablacije hormonov, v petih s placebom kontroliranih kliničnih preskušanjih iii. faze.

ablation of high-grade dysplasia (hgd) in patients with barrett's oesophagus (bo).
fotodinamično zdravljenje (pdt, photodynamic therapy) s photobarrom je indicirano v primeru odprave displazije visoke stopnje (hgd, 'high-grade dysplasia) pri bolnikih z barrettovim požiralnikom (bp).

based on 684 evaluable patients, the overall ablation success rate assessed by neck ultrasounds and stimulated tg levels was 92%, without any statistically significant difference among the four groups.
uspešnost ablacije, ocenjena z ultrazvokom vratu in stimuliranimi ravnmi tg (na osnovi 684 ocenjevanih bolnikov), je bila 92 % in se med štirimi skupinami ni statistično razlikovala.

- ablation of high-grade dysplasia (hgd) in patients with barrett's oesophagus (bo).
fotodinamično zdravljenje (pdt, photodynamic therapy) s photobarrom je indicirano v primeru odprave displazije visoke stopnje (hgd, 'high- grade dysplasia) pri bolnikih z barrettovim požiralnikom (bp).

as assessed by radioiodine imaging and stimulated tg levels (n = 421), ablation success rates were approximately 86% in all four treatment groups.
uspešnost ablacije, ocenjena s slikanjem z radioaktivnim jodom in stimuliranimi ravnmi tg (n = 421), je bila v vseh štirih terapevtskih skupinah približno 86 % in se med štirimi skupinami ni statistično razlikovala.

at final analysis, performed at a minimum of 24 months follow-up, a statistically significant percentage of patients (77%) in the photobarr pdt + om group demonstrated complete hgd ablation compared to 39% of patients in the om alone group (p<0.0001).
v končni analizi, opravljeni po najmanj 24-mesečnem obdobju spremljanja in izvajanja kontrolnih pregledov, je statistično pomemben odstotek bolnikov (77%) v skupini, ki je dobivala photobarr pdt + om, pokazal popolno ablacijo hgd v primerjavi z 39% bolnikov v skupini, zdravljeni samo z om (p<0,0001).